Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Akindele, K."'
Autor:
Pearson, A.D.J., Federico, S., Gatz, S.A., Ortiz, M., Lesa, G., Scobie, N., Gounaris, I., Weiner, S.L., Weigel, B., Unger, T.J., Stewart, E., Smith, M., Slotkin, E.K., Reaman, G., Pappo, A., Nysom, K., Norga, K., McDonough, J., Marshall, L.V., Ludwinski, D., Ligas, F., Karres, D., Kool, M., Horner, T.J., Henssen, A., Heenen, D., Hawkins, D.S., Gore, L., Bender, J.G., Galluzzo, S., Fox, E., de Rojas, T., Davies, B.R., Chakrabarti, J., Carmichael, J., Bradford, D., Blanc, P., Bernardi, R., Benchetrit, S., Akindele, K., Vassal, G.
DNA damage response inhibitors have a potentially important therapeutic role in paediatric cancers; however, their optimal use, including patient selection and combination strategy, remains unknown. Moreover, there is an imbalance between the number
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::1710b7ed5065a0dad58ad299181a3dc3
http://edoc.mdc-berlin.de/23585/1/23585oa.pdf
http://edoc.mdc-berlin.de/23585/1/23585oa.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ebuka E, David, Muhammad A, Yameen, Ikechuku O, Igwenyi, Chidinma N, David, Valentine, Nwobodo, Akindele K, Ismail
Publikováno v:
Pediatric Gastroenterology, Hepatology & Nutrition
Purpose To determine the effect of zinc deficiency on fecal protein, electrolyte, and short-chain fatty acid levels in both heat-stable (ST) and heat-labile (LT) enterotoxigenic Escherichia coli (ETEC)-induced diarrhea in rats. Methods Albino rats, w
Autor:
Ebuka E. David, Muhammad A. Yameen, Ikechuku O. Igwenyi, Chidinma N. David, Valentine Nwobodo, Akindele K. Ismail
Publikováno v:
Pediatric Gastroenterology, Hepatology & Nutrition. 25:79
Autor:
David, Ebuka E., Yameen, Muhammad A., Igwenyi, Ikechuku O., David, Chidinma N., Nwobodo, Valentine, Ismail, Akindele K.
Publikováno v:
Pediatric Gastroenterology, Hepatology & Nutrition; Jan2022, Vol. 25 Issue 1, p79-86, 8p
Publikováno v:
Disability & Rehabilitation; 1994, Vol. 16 Issue 2, p58-62, 5p
Publikováno v:
Medicine & Science in Sports & Exercise; 1993 Supplement, Vol. 25, pS161-S161, 1p
Autor:
Pearson ADJ; ACCELERATE, c/o BLSI, Clos Chapelle-aux-Champs 30, Bte 1.30.30 BE-1200 Brussels, Belgium. Electronic address: andy1pearson@btinternet.com., Federico S; St Jude Children's Research Hospital, Memphis, TN, USA., Gatz SA; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Ortiz M; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lesa G; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Amsterdam, the Netherlands., Scobie N; Zoe4Life, Sullens, Switzerland., Gounaris I; Merck Serono Ltd (an affiliate of Merck KGaA, Darmstadt, Germany), Feltham, UK., Weiner SL; Children's Cancer Cause, Washington, DC, USA., Weigel B; University of Minnesota, Minneapolis, MN, USA., Unger TJ; Repare Therapeutics, Cambridge, MA, USA., Stewart E; St Jude Children's Research Hospital, Memphis, TN, USA., Smith M; National Cancer Institute, Bethesda, MD, USA., Slotkin EK; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reaman G; US Food and Drug Administration, Silver Springs, MD, USA., Pappo A; St Jude Children's Research Hospital, Memphis, TN, USA., Nysom K; Righospitalet, Copenhagen, Denmark., Norga K; Antwerp University Hospital, Antwerp, Belgium; Paediatric Committee of the European Medicines Agency (EMA), Amsterdam, the Netherlands; Federal Agency for Medicines and Health Products, Brussels, Belgium., McDonough J; The Andrew McDonough B+ Foundation, Wilmington, DE, USA., Marshall LV; The Royal Marsden NHS Foundation Hospital, The Institute of Cancer Research, Sutton, Surrey, UK., Ludwinski D; Solving Kids' Cancer, New York, NY, USA., Ligas F; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Amsterdam, the Netherlands., Karres D; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Division, European Medicines Agency (EMA), Amsterdam, the Netherlands., Kool M; Hopp Children's Cancer Center, Heidelberg, Germany., Horner TJ; GSK, Collegeville, PA, USA., Henssen A; Charité Berlin, Berlin, Germany., Heenen D; KickCancer, Brussels, Belgium., Hawkins DS; Seattle Children's Hospital, Seattle, WA, USA; Children's Oncology Group, Seattle, WA, USA., Gore L; Children's Hospital Colorado, Aurora, CO, USA; University of Colorado School of Medicine, Aurora, CO, USA., Bender JG; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Galluzzo S; Italian Medicine Agency (AIFA), Rome, Italy., Fox E; St Jude Children's Research Hospital, Memphis, TN, USA., de Rojas T; ACCELERATE, c/o BLSI, Clos Chapelle-aux-Champs 30, Bte 1.30.30 BE-1200 Brussels, Belgium., Davies BR; AstraZeneca, Cambridge, UK., Chakrabarti J; Pfizer, Tadworth, UK., Carmichael J; The Royal Marsden NHS Foundation Hospital, The Institute of Cancer Research, Sutton, Surrey, UK., Bradford D; US Food and Drug Administration, Silver Springs, MD, USA., Blanc P; Imagine for Margo, Paris, France., Bernardi R; Genentech, a Member of the Roche Group, South San Francisco, CA, USA., Benchetrit S; National Agency for the Safety of Medicine and Health Products, Paris, France., Akindele K; The Dorcas Foundation, Lagos, Nigeria., Vassal G; ACCELERATE, c/o BLSI, Clos Chapelle-aux-Champs 30, Bte 1.30.30 BE-1200 Brussels, Belgium; Gustave Roussy Cancer Centre, Paris, France.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Sep; Vol. 190, pp. 112950. Date of Electronic Publication: 2023 Jun 21.